{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-10T12:25:40.070427+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals (VRTX): Assessing Valuation After a Strong Multi‑Quarter Run and Recent Pullback - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Assessing Valuation After a Strong Multi‑Quarter Run and Recent Pullback</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-10T11:39:10+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Vertex's gene therapy shows promise in younger children with blood disorders - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5\" target=\"_blank\">Vertex's gene therapy shows promise in younger children with blood disorders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-12-06T12:04:29+00:00",
      "source": "Reuters"
    },
    {
      "title": "Wells Fargo Adjusts PT on Vertex Pharmaceuticals to $515 From $460, Maintains Overweight Rating - marketscreener.com",
      "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOYllhQ1kwMDA0Z0NYNHgyU3ZNTUtMYlNuRk52MlUtSzVILWJQNmtzNU9OZUpzRDRsNFpnRGJPMWwwLUJ0clZwUWFDUDQ5RzU1U29FcHNoMnNYRjlsc2FFTEI4Q25KMTRZZHdEcE5QVVVnMHUzS1dBYWhXcFRPM3FQS0l5dFNERnNYU2xxa3FFX3IwLXZrcUYwYjMyaE00VjRzZ1M1c3JHT2hESV96VHVDd294N21uR1dhQWIyRjQ2Z0NwbjE3ck5yUnc3U3lzTk5QTTFUaTZINUkyRWRSSEE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOYllhQ1kwMDA0Z0NYNHgyU3ZNTUtMYlNuRk52MlUtSzVILWJQNmtzNU9OZUpzRDRsNFpnRGJPMWwwLUJ0clZwUWFDUDQ5RzU1U29FcHNoMnNYRjlsc2FFTEI4Q25KMTRZZHdEcE5QVVVnMHUzS1dBYWhXcFRPM3FQS0l5dFNERnNYU2xxa3FFX3IwLXZrcUYwYjMyaE00VjRzZ1M1c3JHT2hESV96VHVDd294N21uR1dhQWIyRjQ2Z0NwbjE3ck5yUnc3U3lzTk5QTTFUaTZINUkyRWRSSEE?oc=5\" target=\"_blank\">Wells Fargo Adjusts PT on Vertex Pharmaceuticals to $515 From $460, Maintains Overweight Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">marketscreener.com</font>",
      "published": "2025-12-10T12:13:54+00:00",
      "source": "marketscreener.com"
    },
    {
      "title": "Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5\" target=\"_blank\">Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2025-12-07T01:15:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPY2d6X1piMmhPM010UzdSMndVTVdiSVRBQnpCTkhTZ25hekR1S3I5SDBiVGlkdXJoNk1WbDJNQWRNcEJ2OTRYTkZlTzFxYkxzMTZEVnYxcnpzRGRmZTBtZkgza3NWb1VmbWlSbTIyMHVGWTVjNFJLM21DOENRSWdsX0FZdVRWZUk3S0tLb2FZeEp2ak9nQlJOUw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPY2d6X1piMmhPM010UzdSMndVTVdiSVRBQnpCTkhTZ25hekR1S3I5SDBiVGlkdXJoNk1WbDJNQWRNcEJ2OTRYTkZlTzFxYkxzMTZEVnYxcnpzRGRmZTBtZkgza3NWb1VmbWlSbTIyMHVGWTVjNFJLM21DOENRSWdsX0FZdVRWZUk3S0tLb2FZeEp2ak9nQlJOUw?oc=5\" target=\"_blank\">Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-12-07T00:15:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPTGh0QjVYaFpGMWpWSFAzZ0d3c0xKU2F5OGktMldZTDJ1ZklfZUpIOUI2bzRSZTZ2Zm9wSUhPRGdTSW9oLW56MWhYaHY2bC1GRGZtZVAxUXV2eWlTMzRVS2hJQWtLa0hwVURJemQzOVd0c1lTdzE3NzNqSThFS3VxZnROVVA2YklM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPTGh0QjVYaFpGMWpWSFAzZ0d3c0xKU2F5OGktMldZTDJ1ZklfZUpIOUI2bzRSZTZ2Zm9wSUhPRGdTSW9oLW56MWhYaHY2bC1GRGZtZVAxUXV2eWlTMzRVS2hJQWtLa0hwVURJemQzOVd0c1lTdzE3NzNqSThFS3VxZnROVVA2YklM?oc=5\" target=\"_blank\">Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-08T14:50:04+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex CRISPR therapy hits early goal in children with blood disorders - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPa2ItUVA2YzZOSWN0WV85QmE3ZVhPLXZ0ZlRvR3JYMlNUcGpqbXNhYkk1cjBuMlVBenplRWp5OUxBY29ZMDZYQ2NCWHg4a0kta1RQcmFRVzlvSXVyTzkxNlVHZ181aWxmcFdpbE1BMEd0YUp4U0k1U3QzeEFKXy16cGR2aHMzaFR2ODVwTEhMTFQ2dDFUVC0yZQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPa2ItUVA2YzZOSWN0WV85QmE3ZVhPLXZ0ZlRvR3JYMlNUcGpqbXNhYkk1cjBuMlVBenplRWp5OUxBY29ZMDZYQ2NCWHg4a0kta1RQcmFRVzlvSXVyTzkxNlVHZ181aWxmcFdpbE1BMEd0YUp4U0k1U3QzeEFKXy16cGR2aHMzaFR2ODVwTEhMTFQ2dDFUVC0yZQ?oc=5\" target=\"_blank\">Vertex CRISPR therapy hits early goal in children with blood disorders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-12-06T13:24:13+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "State Street Corp Has $5.24 Billion Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNWXViZUZGWHdycHRtZkRWOW9rVHhhbmVZc21EU1R2UmRkOEpNd2NVSnprOFdVZk1ycFBPX0JhRnRrTVNlZ1JrY1ZJbVE3NVlVZFE2WG15S1JvVzA1Z1FvaEpGbnJEcm1CU25MVHZqcTNSMXlKTEd1OWhXSkFtRFNhbzNvMkVwaklyVHZkak5NMjYwMXgwbG9RQ3M3RTREOEJnSzEwajk5N2cxeHNKM1ZzVGlDZldMRlpDSEt3ek51REgyWjAxQ2lvV2F6UHFhbGIxNmcxNXZDU2EwRWRWY0o3TQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNWXViZUZGWHdycHRtZkRWOW9rVHhhbmVZc21EU1R2UmRkOEpNd2NVSnprOFdVZk1ycFBPX0JhRnRrTVNlZ1JrY1ZJbVE3NVlVZFE2WG15S1JvVzA1Z1FvaEpGbnJEcm1CU25MVHZqcTNSMXlKTEd1OWhXSkFtRFNhbzNvMkVwaklyVHZkak5NMjYwMXgwbG9RQ3M3RTREOEJnSzEwajk5N2cxeHNKM1ZzVGlDZldMRlpDSEt3ek51REgyWjAxQ2lvV2F6UHFhbGIxNmcxNXZDU2EwRWRWY0o3TQ?oc=5\" target=\"_blank\">State Street Corp Has $5.24 Billion Holdings in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-09T13:11:37+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-09",
      "close": 437.010009765625
    },
    "history": [
      {
        "date": "2025-12-01",
        "close": 425.6000061035156
      },
      {
        "date": "2025-12-02",
        "close": 433.1499938964844
      },
      {
        "date": "2025-12-03",
        "close": 463.1300048828125
      },
      {
        "date": "2025-12-04",
        "close": 457.3599853515625
      },
      {
        "date": "2025-12-05",
        "close": 455.4800109863281
      },
      {
        "date": "2025-12-08",
        "close": 442.0400085449219
      },
      {
        "date": "2025-12-09",
        "close": 437.010009765625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}